» Articles » PMID: 30542664

Tissue and Host Species-specific Transcriptional Changes in Models of Experimental Visceral Leishmaniasis

Overview
Date 2019 Jan 11
PMID 30542664
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

: Human visceral leishmaniasis, caused by infection with or is a potentially fatal disease affecting 50,000-90,000 people yearly in 75 disease endemic countries, with more than 20,000 deaths reported. Experimental models of infection play a major role in understanding parasite biology, host-pathogen interaction, disease pathogenesis, and parasite transmission. In addition, they have an essential role in the identification and pre-clinical evaluation of new drugs and vaccines. However, our understanding of these models remains fragmentary. Although the immune response to infection in mice has been extensively characterized, transcriptomic analysis capturing the tissue-specific evolution of disease has yet to be reported. : We provide an analysis of the transcriptome of spleen, liver and peripheral blood of BALB/c mice infected with . Where possible, we compare our data in murine experimental visceral leishmaniasis with transcriptomic data in the public domain obtained from the study of -infected hamsters and patients with human visceral leishmaniasis. Digitised whole slide images showing the histopathology in spleen and liver are made available via a dedicated website, www.leishpathnet.org. Our analysis confirms marked tissue-specific alterations in the transcriptome of infected mice over time and identifies previously unrecognized parallels and differences between murine, hamster and human responses to infection. We show commonality of interferon-regulated genes whilst confirming a greater activation of type 2 immune pathways in infected hamsters compared to mice. Cytokine genes and genes encoding immune checkpoints were markedly tissue specific and dynamic in their expression, and pathways focused on non-immune cells reflected tissue specific immunopathology. Our data also addresses the value of measuring peripheral blood transcriptomics as a potential window into underlying systemic disease.  Our transcriptomic data, coupled with histopathologic analysis of the tissue response, provide an additional resource to underpin future mechanistic studies and to guide clinical research.

Citing Articles

The intersection of host metabolism and immune responses to infection with kinetoplastid and apicomplexan parasites.

Ewald S, Nasuhidehnavi A, Feng T, Lesani M, McCall L Microbiol Mol Biol Rev. 2024; 88(1):e0016422.

PMID: 38299836 PMC: 10966954. DOI: 10.1128/mmbr.00164-22.


infection upregulates and engages host macrophage Argonaute 1, and system-wide proteomics reveals Argonaute 1-dependent host response.

Moradimotlagh A, Chen S, Koohbor S, Moon K, Foster L, Reiner N Front Immunol. 2023; 14:1287539.

PMID: 38098491 PMC: 10720368. DOI: 10.3389/fimmu.2023.1287539.


Gene Expression Profiling of Classically Activated Macrophages in Infection: Response to Metabolic Pre-Stimulus with Itaconic Acid.

Palacios G, Vega-Garcia E, Valladares B, Perez J, Dorta-Guerra R, Carmelo E Trop Med Infect Dis. 2023; 8(5).

PMID: 37235312 PMC: 10223644. DOI: 10.3390/tropicalmed8050264.


Mass spectrometry imaging identifies altered hepatic lipid signatures during experimental infection.

Tans R, Dey S, Dey N, Cao J, Paul P, Calder G Front Immunol. 2022; 13:862104.

PMID: 36003389 PMC: 9394181. DOI: 10.3389/fimmu.2022.862104.


Leishmania donovani Impedes Antileishmanial Immunity by Suppressing Dendritic Cells via the TIM-3 Receptor.

Akhtar M, Kumar S, Sen P mBio. 2022; 13(4):e0330921.

PMID: 35924848 PMC: 9426438. DOI: 10.1128/mbio.03309-21.


References
1.
Faleiro R, Kumar R, Bunn P, Singh N, Bhushan Chauhan S, Sheel M . Combined Immune Therapy for the Treatment of Visceral Leishmaniasis. PLoS Negl Trop Dis. 2016; 10(2):e0004415. PMC: 4752322. DOI: 10.1371/journal.pntd.0004415. View

2.
Saha A, Biswas A, Srivastav S, Mukherjee M, Das P, Ukil A . Prostaglandin E2 negatively regulates the production of inflammatory cytokines/chemokines and IL-17 in visceral leishmaniasis. J Immunol. 2014; 193(5):2330-9. DOI: 10.4049/jimmunol.1400399. View

3.
Ato M, Stager S, Engwerda C, Kaye P . Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol. 2002; 3(12):1185-91. DOI: 10.1038/ni861. View

4.
Owens B, Beattie L, Moore J, Brown N, Mann J, Dalton J . IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c⁺ cell populations during visceral leishmaniasis. PLoS Pathog. 2012; 8(7):e1002827. PMC: 3406093. DOI: 10.1371/journal.ppat.1002827. View

5.
Maurya R, Kumar R, Prajapati V, Manandhar K, Sacks D, Sundar S . Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen. Parasite Immunol. 2010; 32(7):479-83. PMC: 2898731. DOI: 10.1111/j.1365-3024.2010.01219.x. View